Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Lung Cancer Video Library - Spanish Language: Video #38 Different Types of Lung Cancer
Anonymous
We are pleased to continue this series of informational videos for our Spanish speaking community. GRACE is pleased to welcome Dr. Rafael Santana-Davila, Assistant Professor with the University of Washington School of Medicine and Seattle Cancer Care Alliance. In this 38th video for the Spanish lung cancer video library, Dr. Santana-Davila joined GRACE to discuss the different types of lung cancer.
[ratingwidget post_id=0]
Please feel free to offer comments and raise questions in our Discussion Forums.
TRANSCRIPTS - Spanish and English download transcripts
Diferentes tipos de cancer de pulmón
Different types of lung cancer
Assistant Professor of Medicine
University of Washington Seattle Cancer Care Alliance
Seattle, Washington
Spanish TRANSCRIPT
El cáncer de pulmón lo dividimos frecuentemente en algo que ha sido histórico desde hace mucho, que es el cáncer de células pequeñas y el de células no pequeñas. El cáncer de células pequeñas, depende de la serie y es alrededor del 10 al 20% de los casos. Mientras que el 80 al 90% de casos de cáncer es de las células no pequeñas, el cual también se divide en cáncer de células escamosas (30% de los casos) y adenocarcinoma (alrededor del 60% de los casos).
El resto, es cáncer de células grandes y otros subtipos de cáncer que no son tan comunes.
English TRANSCRIPT
Lung cancer is frequently divided in small cell cancer and non-small cell cancer. The small cells cancer depends on the blood count and affects about 10 to 20% of all cases. About 80 to 90% of the cases are non-small cells cancer, which is also divided in squamous cells (30%) and adenocarcinoma (in about 60% of patients).
The rest of the cases are large cells and other subtypes of cancer that are not very common.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Recent Comments
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: